Thrombosis and hemorrhage in oncology patients (Q33496899)

27 July 2017

1 reference

title

Thrombosis and hemorrhage in oncology patients (English)

1 reference

27 July 2017

0 references

Bick RL

1

1 reference

27 July 2017

Strauss JF

series ordinal

2

1 reference

27 July 2017

Frenkel EP

series ordinal

3

1 reference

27 July 2017

publication date

1 August 1996

1 reference

Hematology / Oncology Clinics of North America

27 July 2017

published in

1 reference

27 July 2017

volume

10

1 reference

27 July 2017

issue

4

1 reference

27 July 2017

page(s)

875-907

1 reference

Platelet function abnormalities in the myeloproliferative disorders.

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Vincristine therapy of idiopathic and secondary thrombocytopenias

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Hypercoagulability associated with malignant disease and with the postoperative state. Evidence for elevated levels of antihemophilic globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Cancer, F.D.P., and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

The incidence of malignant cells in routine bone-marrow examination

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Disseminated intravascular coagulation and related syndromes: Etiology, pathophysiology, diagnosis, and management

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Alterations of hemostasis associated with malignancy: etiology, pathophysiology, diagnosis and management

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Disseminated intravascular coagulation: a clinical/laboratory study of 48 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

The clinical significance of fibrinogen degradation products

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Bleeding Times, Platelet Adhesion, and Aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Daunomycin and fibrinolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Adriamycin and fibrinolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Prothrombin complex concentrate: use in controlling the hemorrhagic diathesis of chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Plasma fibronectin in acute leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

A human myeloma-produced monoclonal protein directed against the active subpopulation of von Willebrand factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Blood coagulation and fibrinolysis in acute leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Characterization of two direct fibrinogenolytic activities and of one proteolytic inhibitor activity in the human prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Increased fibrinolysin with malignant disease. Report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Microangiopathic haemolytic anaemia: mechanisms of red-cell fragmentation: in vitro studies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

A heparin-like anticoagulant in an 8-month-old boy with acute monoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Abnormalities of platelet function in the myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Selection of patients with malignant ascites for a peritoneovenous shunt

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Fibronectin concentration in plasma of patients with breast cancer, colon cancer, and acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Fibrinolytic activity of human tumors as measured by the fibrin-plate method

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Fibrinogenopenia and fibrinolysis in acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Comparative Studies of Blood Coagulation and Platelet Aggregation in Patients with Cancer and Nonmalignant Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

β-Thromboglobulin and platelet counts - effect of malignancy, infection, age and obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Low molecular weight heparin for Hickman catheter--induced thrombosis in thrombocytopenic patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Migrating thrombophlebitis associated with carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Tamoxifen treatment of metastatic breast cancer and antithrombin III levels

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Problems in the diagnosis and management of acute leukemia in childhool. Comments based on a survey of 100 recent patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Abnormalities of von Willebrand factor in myeloproliferative disease: a relationship with bleeding diathesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Acquired protein C deficiency in patients with breast cancer receiving cyclophosphamide, methotrexate, and 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Treatment of disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Tumor angiogenesis: therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Acute hemorrhagic syndrome with hypofibrinogenemia in metastatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

PLATELET FUNCTION DEFECTS WITH BLEEDING. EARLY MANIFESTATION OF ACUTE LEUKEMIA

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Bleeding and intravascular clotting in malignancy: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Acquired type II von Willebrand's disease: demonstration of a complexed inhibitor of the von Willebrand factor-platelet interaction and response to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Groshong catheter-associated subclavian venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Acute promyelocytic leukemiaA model for understanding the role of the malignant cell in hemostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Heparin treatment for the hemorrhagic diathesis of acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Obstructed central venous catheters. Restoring function with a 12-hour infusion of low-dose urokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Effect of platelet transfusion on hemorrhage in patients with acute leukemia: An autopsy study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Bone-marrow examination in 100 consecutive patients with bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Thrombokinetics in man

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Disseminated intravascular coagulation with the peritoneovenous shunt

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

CAUSES OF DEATH IN ACUTE LEUKEMIA: A TEN-YEAR STUDY OF 414 PATIENTS FROM 1954-1963

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Retinal abnormalities in diseases of the blood

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Venographic surveillance of tunneled venous access devices in adult oncology patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Transfusion therapy in congenital deficiencies of plasma factor XIII.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Mitomycin C associated hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Nonbacterial thrombotic endocarditis associated with bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Circulating heparan sulfate proteoglycan anticoagulant from a patient with a plasma cell disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Pre-Leukaemie Acute Myelogenous Leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Nonbacterial thrombotic endocarditis as a cause of cerebral and myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Sternal marrow in patients with metastatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Acquired von Willebrand syndrome due to an inhibitor specific for von Willebrand factor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Disseminated intravascular coagulation--a complication of chemotherapy in acute myelomonocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Pulmonary embolism as a result of Hickman catheter-related thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Disseminated intravascular coagulation. Complication of LeVeen peritoneovenous shunts

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

THROMBOCYTOSIS ASSOCIATED WITH MALIGNANT DISEASE

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Disseminated intravascular coagulation in acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Vinblastine sulphate in idiopathic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Patterns of metastatic cancer in the spleen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Pathologic cells as procoagulant substance of disseminated intravascular coagulation syndrome in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Pulmonary hypertension, hemolytic anemia, and renal failure. A mitomycin-associated syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Platelet function and intraplatelet von Willebrand factor antigen and fibrinogen in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Coagulation disorders in cancer.I. Clinical and laboratory studies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Thromboses during cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Acquired von Willebrand disease and storage pool disease in chronic myelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Acquired von Willebrand disease due to inhibitor of human myeloma protein specific for von Willebrand factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Role of blood platelets in thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Thrombotic Thrombocytopenic Purpura: An Extended Editorial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

VITAMIN K INDUCED PROTHROMBIN FORMATION: ANTAGONISM BY ACTINOMYCIN D

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Circulating Heparan Sulfate Anticoagulant in a Patient with a Fatal Bleeding Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

The fibrinolytic enzyme system in prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Tumors, mucus production, and hypercoagulability

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Fibrinolytic purpura in acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Acute promyelocytic leukemia with disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Peritoneovenous shunt for palliation of malignant ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

The relationship between the thrombotic and infectious complications of central venous catheters

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Coexistent hypercoagulability and acute hypofibrinogenemia in a patient with prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Abnormalities of blood coagulation in patients with cancer. Fibrinopeptide A generation and tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Disturbances of Hemostasis in Acute Myeloblastic Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Local installation of small doses of streptokinase for treatment of thrombotic occlusions of long-term access catheters

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Coagulation disorders in cancerII. multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Diagnosis and treatment of cancer-related thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Treatment of Waldenstrom's macroglobulinemia by plasmapheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Thrombolytic therapy for catheter-related thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

The efficacy of intensive plasma exchange in acquired von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Hemostasis in malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Coagulation disorders in cancer. 3. Fibrinolysis and inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

DDAVP in acquired von Willebrand syndrome associated with multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Plasma von Willebrand factor proteolysis in patients with chronic myeloproliferative disorders: no possibility of ex vivo degradation by calcium-dependent proteases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Coagulent and fibrinolytic activities in the leukemic cell lysates

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Diagnostic efficacy of a simple radioimmunoassay test for fibrinogen/fibrin fragments containing the B beta 15-42 sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

Nonspecificity of the protamine test for disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970374-9

7 January 2021

10.1016/S0889-8588(05)70374-9

Identifiers

DOI

1 reference

27 July 2017

1 reference